SYRA HEALTH CORP - CLASS A (SYRA) Stock Analyst Earnings Estimates
NASDAQ:SYRA - Nasdaq - US87168W2035 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 5.62M 298.58% | 5.515M -1.87% | 7.982M 44.73% | |
| EBITDA YoY % growth | -2.075M -1,037,650.00% | -2.839M -36.80% | -3.702M -30.41% | |
| EBIT YoY % growth | -2.09M | -2.888M -38.16% | -3.765M -30.38% | |
| Operating Margin | -37.19% | -52.36% | -47.17% | |
| EPS YoY % growth | N/A | N/A | N/A -6.00% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 55.38% | -0.07 | % | |
| Q3 2024 Q2Q % growth | -0.06 | -0.21 | 0.15 | 71.99% |
| Q2 2024 Q2Q % growth | -0.21 | -0.19 | -0.02 | -8.36% |
| Q1 2024 Q2Q % growth | -0.22 | -0.19 | -0.03 | -13.52% |
| Q4 2023 Q2Q % growth | -0.16 | -0.09 | -0.07 | -74.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 2.007M 13.63% | 2.052M | -45.3K | -2.21% |
| Q3 2024 Q2Q % growth | 2.253M 42.48% | 2.031M | 222K | 10.93% |
| Q2 2024 Q2Q % growth | 1.97M 100.99% | 1.825M | 144.68K | 7.93% |
| Q1 2024 Q2Q % growth | 1.752M 47.26% | 1.43M | 322.34K | 22.54% |
| Q4 2023 Q2Q % growth | 1.766M -68.56% | 2.273M | -507K | -22.31% |
| Q2 2023 Q2Q % growth | 980K -17.65% | % | ||
| Q1 2023 Q2Q % growth | 1.19M 25.26% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |